Less Ads, More Data, More Tools Register for FREE

Pin to quick picksExperian Regulatory News (EXPN)

Share Price Information for Experian (EXPN)

Share Price is delayed by 15 minutes
Get Live Data
2,619.00    -20.00 (-0.76%)
Bid:
2,621.00
Ask:
2,625.00
Spread: 4.00 (0.153%)
Market Cap: £23.39b
EXPN Live PriceLast checked at - London Stock Exchange

Intraday Experian Share Chart

Capital allocation update

30 Jan 2026 07:00

RNS Number : 9984Q
Experian plc
30 January 2026
 

 

news release

 

 

Capital allocation update: launch of US$1bn share repurchase programme

30 January 2026 - Experian, the global data and technology company, today announces the launch of a US$1bn share repurchase programme (the Programme).

We continue to trade strongly underpinned by our strategic execution and we expect to end this financial year in a favourable leverage position. This enables us to continue to invest in the business while also returning excess capital to shareholders.

 

Given this flexibility, we see opportunity to drive additional shareholder value through the introduction of increased share repurchases. Our medium-term financial framework, capital allocation framework and dividend policy are all unchanged.

 

The Experian plc Board has approved the following Programme:

 

· A share repurchase of up to US$1bn to conclude no later than 30 June 2027. The maximum number of shares that may be repurchased is 89,789,942 pursuant to the authority granted at the 2025 AGM.

· The pace and form of the proposed capital return will be subject to market conditions, and the ongoing assessment of the capital needs of the business. The purpose of the Programme is to reduce the number of shares in issue and to meet obligations arising from employee share plans of c.$200m.

· Experian has entered into an engagement with JP Morgan in connection with the first tranche of the Programme, to commence immediately.

 

This announcement contains Inside Information.

Company LEI: 635400RXXHHYT1JTSZ26.

 

Contact:

Experian

Nadia Ridout-Jamieson Investor queries +44 (0)20 3042 4220

Gerry Tschopp, Nick Jones Media queries

 

Teneo

Graeme Wilson and Louise Male +44 (0)20 7353 4200

 

About Experian

Experian is a global data and technology company, powering opportunities for people and businesses around the world. We help to redefine lending practices, uncover and prevent fraud, simplify healthcare, deliver digital marketing solutions, and gain deeper insights into the automotive market, all using our unique combination of data, analytics and software. We also assist millions of people to realise their financial goals and help them to save time and money.

We operate across a range of markets, from financial services to healthcare, automotive, agrifinance, insurance, and many more industry segments.

We invest in talented people and new advanced technologies to unlock the power of data and to innovate. A FTSE 100 Index company listed on the London Stock Exchange (EXPN), we have a team of 25,200 people across 33 countries. Our corporate headquarters are in Dublin, Ireland. Learn more at experianplc.com.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
UPDDZGZMRLKGVZM
Date   Source Headline
14th May 202510:42 amRNSAdditional Listing
14th May 20257:24 amRNSFull-year financial report
30th Apr 202510:43 amRNSTotal Voting Rights
30th Apr 20259:30 amRNSAdditional Listing
16th Apr 20259:54 amRNSAdditional Listing
9th Apr 20259:21 amRNSAdditional Listing
2nd Apr 20259:42 amRNSAdditional Listing
2nd Apr 20257:00 amRNSEXPERIAN COMPLETES ACQUISITION OF CLEARSALE
31st Mar 202512:15 pmRNSTotal Voting Rights
26th Mar 20259:40 amRNSAdditional Listing
21st Mar 20255:22 pmRNSTransaction in Own Shares
20th Mar 20259:32 amRNSAdditional Listing
18th Mar 202511:22 amRNSBlock listing Interim Review
14th Mar 20255:20 pmRNSTransaction in Own Shares
13th Mar 20255:38 pmRNSDirector/PDMR Shareholding
13th Mar 20255:29 pmRNSTransaction in Own Shares
12th Mar 20255:04 pmRNSTransaction in Own Shares
11th Mar 20255:28 pmRNSTransaction in Own Shares
10th Mar 20255:25 pmRNSTransaction in Own Shares
28th Feb 20255:29 pmRNSTransaction in Own Shares
28th Feb 20253:16 pmRNSTotal Voting Rights
27th Feb 20255:29 pmRNSTransaction in Own Shares
26th Feb 20255:39 pmRNSTransaction in Own Shares
25th Feb 20255:34 pmRNSTransaction in Own Shares
24th Feb 20255:37 pmRNSTransaction in Own Shares
21st Feb 20255:36 pmRNSTransaction in Own Shares
20th Feb 20255:46 pmRNSTransaction in Own Shares
19th Feb 20255:17 pmRNSTransaction in Own Shares
18th Feb 20255:45 pmRNSTransaction in Own Shares
12th Feb 20257:00 amRNSDirectorate Change
10th Feb 20254:08 pmRNSDirector/PDMR Shareholding
31st Jan 202511:41 amRNSTotal Voting Rights
24th Jan 202510:25 amRNSOutcome of audit tender process
17th Jan 20255:14 pmRNSFirst interim dividend
16th Jan 20255:14 pmRNSBond Issue
15th Jan 20257:00 amRNSExperian Q3 FY25 trading update
31st Dec 202410:16 amRNSTotal Voting Rights
23rd Dec 20241:39 pmRNSShare repurchase programme
20th Dec 20249:00 amRNSElections for first interim dividend
12th Dec 20249:25 amRNSDirector Declaration
29th Nov 20243:56 pmRNSTotal Voting Rights
13th Nov 20247:00 amRNSHalf-year Report
5th Nov 20241:51 pmRNSTotal Voting Rights - Amendment
31st Oct 202412:19 pmRNSTotal Voting Rights
4th Oct 202412:44 pmRNSExperian to acquire Clearsale in Brazil
30th Sep 202412:30 pmRNSTotal Voting Rights
30th Sep 20248:29 amRNSExperian Completes Acquisition of Ilion
16th Sep 202412:10 pmRNSBlock listing Interim Review
4th Sep 20243:30 pmRNSBond Issue
30th Aug 20243:15 pmRNSTotal Voting Rights

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.